FDA Approved: DOFETILIDE — Supplemental Application (Bionpharma Inc.)

View source ↗

Summary

FDA approved a supplemental application for dofetilide filed by Bionpharma Inc. under an ANDA, approving a change to the approved product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Atrial Flutter

Drugs mentioned

• Dofetilide (dofetilide)

Snippet

SUPPL AP for DOFETILIDE (DOFETILIDE)